|
1
|
Friedman SL: Liver fibrosis-from bench to
bedside. J Hepatol. 38(Suppl 1): 38–53. 2003. View Article : Google Scholar
|
|
2
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gines P, Cardenas A, Arroyo V and Rodes J:
Management of cirrhosis and ascites. N Engl J Med. 350:1646–1654.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friedman SL: Liver firosis - from bench to
bedside. J Hepatol. 38(Suppl 1): S38–S53. 2003. View Article : Google Scholar
|
|
5
|
Chen SL and Morgan TR: The natural history
of hepatitis C virus (HCV) infection. Int J Med Sci. 3:47–52. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soyer MT, Ceballos R and Aldrete JS:
Reversibility of severe hepatic damage caused by jejunoileal bypass
after re-establishment of normal intestinal continuity. Surgery.
79:601–604. 1976.PubMed/NCBI
|
|
7
|
Friedman SL, Roll FJ, Boyles J and Bissell
DM: Hepatic lipocytes: the principal collagen-producing cells of
normal rat liver. ProcNatlAcadSci USA. 82:8681–8685. 1985.
View Article : Google Scholar
|
|
8
|
Geerts A: History, heterogeneity,
developmental biology and functions of quiescent hepatic stellate
cells. Semin Liver Dis. 21:311–335. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li D and Friedman SL: Liver fibrogenesis
and the role of hepatic stellate cells: new insights and prospects
for therapy. J GastroenterolHepatol. 14:618–633. 1999.
|
|
10
|
Tsukada S, Parsons CJ and Rippe RA:
Mechanisms of liver fibrosis. ClinChimActa. 364:33–60. 2006.
|
|
11
|
Wu J and Zern MA: Hepatic stellate cells:
a target for the treatment of liver fibrosis. J Gastroenterol.
35:665–672. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee MK, Ha NR, Yang H, Sung SH, Kim GH and
Kim YC: Antiproliferative activity of triterpenoids from
Ecliptaprostrata on hepatic stellate cells. Phytomedicine.
15:775–780. 2008. View Article : Google Scholar
|
|
14
|
Cichoz-Lach H and Michalak A: Oxidative
stress as a crucial factor in liver diseases. World J
Gastroenterol. 20:8082–8091. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tahan V, Ozaras R, Canbakan B, et al:
Melatonin reduces dimethylnitrosamine-induced liver fibrosis in
rats. J Pineal Res. 37:78–84. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Poli G: Pathogenesis of liver fibrosis:
role of oxidative stress. Mol Aspects Med. 21:49–98. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Q, Zhao XL, Sun J, Jiang SG and Gong
XF: Anti-proliferative and apoptosis-inducing activities of juglone
in LS-174T cells. Bangladesh J Pharmacol. 8:65–72. 2013. View Article : Google Scholar
|
|
18
|
Aithal BK, Kumar MR, Rao BN, Udupa N and
Rao BS: Juglone, a naphthoquinone from walnut, exerts cytotoxic and
genotoxic effects against cultured melanoma tumor cells. Cell
BiolInt. 33:1039–1049. 2009.
|
|
19
|
Thomson RH: Naturally Occurring Quinones.
Academic Press; New York, NY: pp. 257–276. 1971
|
|
20
|
Seshadri P, Rajaram A and Rajaram R:
Plumbagin and juglone induce caspase-3-dependent apoptosis
involving the mitochondria through ROS generation in human
peripheral blood lymphocytes. Free RadicBiol Med. 51:2090–2107.
2011. View Article : Google Scholar
|
|
21
|
Funt RC and Martin J: Black walnut
toxicity to plants, humans and horses. Ohio State University
Extension Fact sheet HYG-1148-93; 1993
|
|
22
|
Ji YB, Qu ZY and Zou X: Juglone-induced
apoptosis in human gastric cancer SGC-7901 cells via the
mitochondrial pathway. ExpToxicolPathol. 63:69–78. 2011.
|
|
23
|
Lowry OH, Rosebrough NJ, Farr AL and
Randall RJ: Protein measurement with the Folin phenol reagent. J
BiolChem. 193:265–275. 1951.
|
|
24
|
Jiao J, Friedman SL and Aloman C: Hepatic
fibrosis. CurrOpinGastroenterol. 25:223–229. 2009.
|
|
25
|
Ruehl M, Muche M, Freise C, et al:
Hydroxyproline-containing collagen analogs trigger the release and
activation of collagen-sequestered proMMP-2 by competition with
prodomain-derived peptide P33-42. Fibrogenesis Tissue Repair.
4:12011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen JC, Tsai CC, Chen LD, Chen HH and
Wang WC: Therapeutic effect of gypenoside on chronic liver injury
and fibrosis induced by CC14 in rats. Am J Chin Med. 28:175–185.
2000. View Article : Google Scholar
|
|
27
|
Meng Z, Wang Y, Wang L, et al: FXR
regulates liver repair after CC14-induced toxic injury.
MolEndocrinol. 24:886–897. 2010.
|
|
28
|
Giannini EG, Testa R and Savarino V: Liver
enzyme alteration: A guide for clinicians. CMAJ. 172:367–379. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Radosavljevic T, Mladenovic D and Vucevic
D: The role of oxidative stress in alcoholic liver injury. Med
Pregl. 62:547–553. 2009.In Serbian. View Article : Google Scholar
|
|
30
|
Casini A, Ceni E, Salzano R, et al:
Neutrophil derived superoxide anion induceslipid peroxidation and
stimulates collagen synthesis in human hepatic stellate cells: role
of nitric oxide. Hepatology. 25:361–367. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nieto N, Friedman SL and Cederbaum AI:
Cytochrome P450 2El-derived reactive oxygen species mediate
paracrine stimulation of collagen I protein synthesis byhepatic
stellate cells. J BiolChem. 277:9853–9864. 2002.
|
|
32
|
SvegliatiBaroni G, D'Ambrosio L, Ferretti
G, et al: Fibrogenic effect of oxidative stress on rat hepatic
stellate cells. Hepatology. 27:720–726. 1998. View Article : Google Scholar
|
|
33
|
Campbell JS, Hughes SD, Gilbertson DG, et
al: Platelet derived growth factor C induces liver fibrosis,
steatosis and Hepatocellular carcinoma. ProcNatlAcadSci USA.
102:3389–3394. 2005. View Article : Google Scholar
|
|
34
|
Friedman SL: Molecular regulation of
hepatic fibrosis, an integrated cellular response to tissue injury.
J BiolChem. 275:2247–2250. 2000.
|
|
35
|
Wang YD, Jia LW and Li CM: Hepatic content
of collagens and laminin in rat model of experimental liver
fibrosis. World J Gastroenterol. 6:732000.
|
|
36
|
Islam S, Antonsson L, Westin J and Lagging
M: Cirrhosis in hepatitis C virus-infected patients can be excluded
using an index of standard biochemical serum markers. Scand J
Gastroenterol. 40:867–872. 2005. View Article : Google Scholar : PubMed/NCBI
|
